NYLIM WMC Value Class C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
NYLIM WMC Value Class C MMPCX
- NAV / 1-Day Return $23.25 / +0.35 %
- Fund Size $902.1M
- Adjusted Expense Ratio 1.980%
- Net Expense Ratio 1.980%
- Fee Level: Distribution High
- Share Class Type Level Load
- Morningstar Category Large Value
- Equity Style Box (Funds) Large Value
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.92%
- Turnover Ratio 43%
Morningstar’s Analysis MMPCX
Will MMPCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Microsoft Corp | 6.77 | 62M | Technology |
JPMorgan Chase & Co | 3.53 | 32M | Financial Services |
Merck & Co Inc | 2.78 | 25M | Healthcare |
Johnson & Johnson | 2.70 | 25M | Healthcare |
Cisco Systems Inc | 2.04 | 19M | Technology |
UnitedHealth Group Inc | 2.01 | 18M | Healthcare |
Elevance Health Inc | 1.82 | 17M | Healthcare |
Intercontinental Exchange Inc | 1.80 | 16M | Financial Services |
Gilead Sciences Inc | 1.80 | 16M | Healthcare |
Pfizer Inc | 1.77 | 16M | Healthcare |